NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Home / Brian Armstrong’s NewLimit Raises $435M for Human Trials
NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
According to a recent SoSoValue update, U.S. spot Bitcoin ETFs recorded $85.85 million in daily total net inflow on June
Bitcoin has entered a period where preparations for quantum-resistant security should begin immediately, according to a new report from Coinbase’s
Anthropic has suspended access to its newly launched Fable 5 and Mythos 5 artificial intelligence models after receiving a U.S.